Navigation Links
China Nepstar Chain Drugstore Awarded Prestigious Title of '2007 Best Drugstore Chain in China' by China Drugstore Magazine

SHENZHEN, China, April 10 /Xinhua-PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that it has been awarded the title of "Best Drugstore Chain of 2007 in China" by China Drugstore magazine, a leading trade publication in the Drugstore industry in China.

China Drugstore magazine has more than 100,000 industry subscribers and has ranked China's drugstore chains for the past eight years. In bestowing the Best Drugstore Chain title upon China Nepstar, the magazine cited the Company's success in achieving rapid store network expansion and profit increases at the same time.

"The title awarded by China Drugstore is another testimony of our professional excellence," said Mr. Jiannong Qian, chief executive officer of Nepstar." In 2008, we plan to accelerate new store openings, seek more acquisitions, implement advanced supply-chain systems, improve employee skills and further enhance customer relations. We will continue to strengthen our brand awareness and recognition among Chinese consumers."

China Nepstar currently has outlets in 62 cities in China, with 7 million members enrolled in its Customer Loyalty Program nationwide.

At the end of 2007, the Company had store staff of 12,500 people. Nepstar store staff participate in company-wide professional training programs to enhance their skills and expertise, with pharmacists participating in 20 training sessions and ordinary floor staff participating in more than 10 training sessions per year.

In addition, the Company actively organizes and involves itself in community services and charitable activities. For example, In March 2008, it launched a charitable initiative to raise awareness of women's health issues among low-income working women residents in Guangdong Province.

About China Nepstar Chain Drugstore Ltd.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China's largest retail drugstore chain based on the number of directly operated stores. As of December 31, 2007, the Company had 2,002 stores across 62 cities, one headquarters distribution center and 11 regional distribution centers in China. China Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide customers with high-quality, professional and convenient Drugstore services and a wide variety of other merchandise, including over-the-counter ("OTC") drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables. China Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust economic growth in China and to take advantage of the demographic trend in China to achieve a strong brand and leading market position. For further information, please go to .

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

For more information, please contact:

In China:

Lucia Qian

Marketing and IR Director

China Nepstar Chain Drugstore Ltd.

Tel: +86-755-2641-4065


In the United States:

Dixon Chen

Investor Relations

The Global Consulting Group

Tel: +1-646-284-9403


Ivette Almeida

Media Relations

The Global Consulting Group

Tel: +1-646-284-9455


SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc.
2. Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area
3. Mindray to Attend the JPMorgan 4th Annual China Conference
4. Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
5. China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent
6. China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results
7. China Shenghuo Pharmaceutical Holdings, Inc. to Present at Brean Murray Carret & Co. Mainland China Investor Tour
8. China Nepstar Chain Drugstore to Accept TransCard at Shenzhen Outlets
9. China Bionanometer Industries (CBIU) Describes their Current Production Capacity and Product Lines
10. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
11. China Shenghuo Reports Full Year 2007 Financial Results
Post Your Comments:
(Date:12/1/2015)... Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... United States, today announced that its iconic bottle has won top honors in Beverage ... category. The Company also announced that it has been selected as a 2015 ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation ... utilization of hospital and nonhospital care, according to a recent study by the Workers ... 16th Edition , found medical payments per claim with more than seven days of ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today ... Golden Bridge Business Awards under the New Products and Services category for its ... sample management software that helps labs organize data and track samples ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... keeping their independence is everything. That is why Hollister Incorporated has launched the ... to offer this next product in the VaPro touch free catheter portfolio,” said ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 ... today announced that its Chief Executive Officer, ... the Oppenheimer Annual Healthcare Conference in New ... in the conference through a webcast on ... , --> ...
(Date:12/1/2015)... India and PITTSBURGH , ... today announced that it expects to be the first ... markets funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate ... mg) for $99 per patient, per year. Mylan partnered ... TLE400. The significantly reduced price could generate savings of ...
(Date:12/1/2015)... Breg, Inc ., a premier provider ... it has been awarded three contracts by Novation, a ... will have access to improved pricing for Breg,s portfolio ... goods dedicated to advancing orthopedic care.  ... population, rising prevalence of chronic conditions and the health ...
Breaking Medicine Technology: